This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Apr;13(4):183.

doi: 10.1038/nrcardio.2016.39. Epub 2016 Mar 10.

Cardioprotection: Cardiotoxicity of anticancer therapy

Irene Fernández-Ruiz

PMID: 26961065
DOI: 10.1038/nrcardio.2016.39

Comment

Cardioprotection: Cardiotoxicity of anticancer therapy

Irene Fernández-Ruiz. Nat Rev Cardiol. 2016 Apr.

. 2016 Apr;13(4):183.

doi: 10.1038/nrcardio.2016.39. Epub 2016 Mar 10.

Author

Irene Fernández-Ruiz

PMID: 26961065
DOI: 10.1038/nrcardio.2016.39

No abstract available

PubMed Disclaimer

Comment on

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.
Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T. Gulati G, et al. Eur Heart J. 2016 Jun 1;37(21):1671-80. doi: 10.1093/eurheartj/ehw022. Epub 2016 Feb 21. Eur Heart J. 2016. PMID: 26903532 Free PMC article. Clinical Trial.

References

1. Eur Heart J. 2016 Jun 1;37(21):1671-80 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations